Debates between Lord Reid of Cardowan and Baroness Evans of Bowes Park during the 2019 Parliament

Thu 6th Jan 2022

Covid-19

Debate between Lord Reid of Cardowan and Baroness Evans of Bowes Park
Thursday 6th January 2022

(2 years, 4 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Evans of Bowes Park Portrait Baroness Evans of Bowes Park (Con)
- Hansard - - - Excerpts

I completely agree that we have a duty of care, which is why we have implemented a whole range of measures to which noble Lords were alerted earlier this week. It would be a great disservice to the whole commission to suggest that that is not at the front and centre of what we are doing, but we are trying to balance that with being able to work in an effective manner—noble Lords made it clear that they did not believe that hybrid working was as effective as being here—and we are meeting regularly to assess the situation as things happen. We are asking millions of people to go to work in such circumstances. I think we should show by example, but I also genuinely believe that we are providing a safe working environment here for both Peers and staff.

Lord Reid of Cardowan Portrait Lord Reid of Cardowan (Lab)
- Hansard - -

My Lords, given the chronic shortage of lateral flow tests, can the noble Baroness confirm press reports over the Christmas and new year period that no sooner had one of the major distributors received 2.5 million lateral flow tests then it went on holiday for a week? Has there been any follow-up on that to discover whether that was an isolated incident, or has it been a recurrent pattern?

Baroness Evans of Bowes Park Portrait Baroness Evans of Bowes Park (Con)
- Hansard - - - Excerpts

The noble Lord is right: there was a reduction in capacity over Christmas. I am sure that conversations are being had, but I go back to the point that I made earlier: in the next couple of months, we are tripling the supply of lateral flow tests from 100 million under our pre-omicron plan to 300 million a month to ensure that we have the testing capacity that we need.